Clorox (NYSE: CLX ) is expected to report Q2 earnings around Feb. 4. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will grow 4.1% and EPS will grow 1.3%.
The average estimate for revenue is $1.27 billion. On the bottom line, the average EPS estimate is $0.80.
Last quarter, Clorox notched revenue of $1.34 billion. GAAP reported sales were 2.5% higher than the prior-year quarter's $1.31 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $1.01. GAAP EPS of $1.01 for Q1 were 3.1% higher than the prior-year quarter's $0.98 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.9%, 110 basis points better than the prior-year quarter. Operating margin was 17.0%, 90 basis points better than the prior-year quarter. Net margin was 9.9%, 10 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $5.63 billion. The average EPS estimate is $4.32.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 837 members out of 874 rating the stock outperform, and 37 members rating it underperform. Among 303 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 300 give Clorox a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $73.38.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Clorox to My Watchlist.